Nasdaq Brings Blockchain to Life

As distributed ledger technology edges closer to widespread adoption, WatersTechnology speaks to Nasdaq's head of blockchain strategy about what's next for this potentially revolutionary technology.

fredrik-voss
Fredrik Voss, head of blockchain strategy, Nasdaq.

Finally, some action. On the penultimate day of 2015, Chain.com, a privately-owned blockchain development company, issued shares to a private investor using Nasdaq's Linq system based on the much-hyped digital ledger technology popularly referred to as blockchain.

Trading shares of private companies is usually considered a laborious, time-consuming, paper-based process where information quickly becomes outdated. Considering the advantages of blockchain ─ especially as a disseminated list of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Systematic tools gain favor in fixed income

Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.

Why recent failures are a catalyst for DLT’s success

Deutsche Bank’s Mathew Kathayanat and Jie Yi Lee argue that DLT's high-profile failures don't mean the technology is dead. Now that the hype has died down, the path is cleared for more measured decisions about DLT’s applications.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here